{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:04:42Z","timestamp":1794848682058,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018556","name":"Suzhou Science and Technology Project","doi-asserted-by":"crossref","award":["SKYD2022103"],"award-info":[{"award-number":["SKYD2022103"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Suzhou Specialized Program for Diagnosis and Treatment Techniques of Clinical Key Diseases","award":["LCZX202103"],"award-info":[{"award-number":["LCZX202103"]}]},{"DOI":"10.13039\/501100007824","name":"Soochow University","doi-asserted-by":"publisher","award":["P112206422"],"award-info":[{"award-number":["P112206422"]}],"id":[{"id":"10.13039\/501100007824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The presence of type 1 diabetes mellitus (T1DM) has been demonstrated to pose an increased risk for developing cardiovascular diseases (CVDs). However, the causal relationships between T1DM and CVDs remain unclear due to the uncontrolled confounding factors and reverse causation bias of the observational studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Summary statistics of T1DM and seven CVDs from the largest available genome-wide association studies (GWAS) of European ancestry and FinnGen biobank were extracted for the primary MR analysis, and the analysis was replicated using UK biobank (UKBB) for validation. Three complementary methods: inverse variance weighted (IVW), weighted median, and MR-Egger were used for the MR estimates. The potential pleiotropic effects were assessed by MR-Egger intercept and MR-PRESSO global test. Additionally, multivariable MR (MVMR) analysis was performed to examine whether T1DM has independent effects on CVDs with adjustment of potential confounding factors. Moreover, a two-step MR approach was used to assess the potential mediating effects of these factors on the causal effects between T1DM and CVDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Causal effects of T1DM on peripheral atherosclerosis (odds ratio [OR]\u2009=\u20091.06, 95% confidence interval [CI]: 1.02\u20131.10;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002)] and coronary atherosclerosis (OR\u2009=\u20091.03, 95% CI: 1.01\u20131.05;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001) were found. The results were less likely to be biased by the horizontal pleiotropic effects (both p values of MR-Egger intercept and MR-PRESSO Global test\u2009&gt;\u20090.05). In the following MVMR analysis, we found the causal effects of T1DM on peripheral atherosclerosis and coronary atherosclerosis remain significant after adjusting for a series of potential confounding factors. Moreover, we found that hypertension partly mediated the causal effects of T1DM on peripheral atherosclerosis (proportion of mediation effect in total effect: 11.47%, 95% CI: 3.23\u201319.71%) and coronary atherosclerosis (16.84%, 95% CI: 5.35\u201328.33%). We didn\u2019t find significant causal relationships between T1DM and other CVDs, including heart failure (HF), coronary artery disease (CAD), atrial fibrillation (AF), myocardial infarction (MI) and stroke. For the reverse MR from CVD to T1DM, no significant causal relationships were identified.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This MR study provided evidence supporting the causal effect of T1DM on peripheral atherosclerosis and coronary atherosclerosis, with hypertension partly mediating this effect.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-023-01974-6","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T13:01:33Z","timestamp":1693659693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Causal associations between type 1 diabetes mellitus and cardiovascular diseases: a Mendelian randomization study"],"prefix":"10.1186","volume":"22","author":[{"given":"Zirui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengkai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,2]]},"reference":[{"issue":"10138","key":"1974_CR1","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","volume":"391","author":"LA DiMeglio","year":"2018","unstructured":"DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391(10138):2449\u201362.","journal-title":"Lancet"},{"key":"1974_CR2","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","volume":"3","author":"A Katsarou","year":"2017","unstructured":"Katsarou A, Gudbj\u00f6rnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA, Lernmark \u00c3. Type 1 diabetes mellitus. Nat Reviews Disease Primers. 2017;3:17016.","journal-title":"Nat Reviews Disease Primers"},{"issue":"12","key":"1974_CR3","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1007\/s00125-021-05571-8","volume":"64","author":"A Green","year":"2021","unstructured":"Green A, Hede SM, Patterson CC, Wild SH, Imperatore G, Roglic G, Beran D. Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia. 2021;64(12):2741\u201350.","journal-title":"Diabetologia"},{"issue":"8","key":"1974_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1001\/jama.2021.11165","volume":"326","author":"JM Lawrence","year":"2021","unstructured":"Lawrence JM, Divers J, Isom S, Saydah S, Imperatore G, Pihoker C, Marcovina SM, Mayer-Davis EJ, Hamman RF, Dolan L, et al. Trends in Prevalence of Type 1 and type 2 diabetes in children and adolescents in the US, 2001\u20132017. JAMA. 2021;326(8):717\u201327.","journal-title":"JAMA"},{"issue":"4","key":"1974_CR5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s11154-021-09642-4","volume":"22","author":"NG Vallianou","year":"2021","unstructured":"Vallianou NG, Stratigou T, Geladari E, Tessier CM, Mantzoros CS, Dalamaga M. Diabetes type 1: can it be treated as an autoimmune disorder? Rev Endocr Metab Disord. 2021;22(4):859\u201376.","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"1974_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255\u2013323.","journal-title":"Eur Heart J"},{"issue":"6","key":"1974_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/CIRCULATIONAHA.118.036068","volume":"139","author":"GR Sousa","year":"2019","unstructured":"Sousa GR, Pober D, Galderisi A, Lv H, Yu L, Pereira AC, Doria A, Kosiborod M, Lipes MA. Glycemic Control, Cardiac Autoimmunity, and long-term risk of Cardiovascular Disease in Type 1 diabetes Mellitus. Circulation. 2019;139(6):730\u201343.","journal-title":"Circulation"},{"issue":"9","key":"1974_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S2213-8587(21)00172-8","volume":"9","author":"V Harjutsalo","year":"2021","unstructured":"Harjutsalo V, Pongrac Barlovic D, Groop PH. Long-term population-based trends in the incidence of cardiovascular disease in individuals with type 1 diabetes from Finland: a retrospective, nationwide, cohort study. Lancet Diabetes Endocrinol. 2021;9(9):575\u201385.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1974_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12933-022-01498-5","volume":"21","author":"M Saeed","year":"2022","unstructured":"Saeed M, Stene LC, Ariansen I, Tell GS, Tapia G, Joner G, Skrivarhaug T. Nine-fold higher risk of acute myocardial infarction in subjects with type 1 diabetes compared to controls in Norway 1973\u20132017. Cardiovasc Diabetol. 2022;21(1):59.","journal-title":"Cardiovasc Diabetol"},{"key":"1974_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijcard.2018.03.099","volume":"262","author":"SC Larsson","year":"2018","unstructured":"Larsson SC, Wallin A, Hakansson N, Stackelberg O, Back M, Wolk A. Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases. Int J Cardiol. 2018;262:66\u201370.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1974_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12933-019-0953-7","volume":"18","author":"YB Lee","year":"2019","unstructured":"Lee YB, Han K, Kim B, Lee SE, Jun JE, Ahn J, Kim G, Jin SM, Kim JH. Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study. Cardiovasc Diabetol. 2019;18(1):157.","journal-title":"Cardiovasc Diabetol"},{"key":"1974_CR12","doi-asserted-by":"publisher","first-page":"110618","DOI":"10.1016\/j.diabres.2023.110618","volume":"198","author":"A Morandi","year":"2023","unstructured":"Morandi A, Piona C, Corradi M, Marigliano M, Giontella A, Orsi S, Emiliani F, Tagetti A, Marcon D, Fava C, et al. Risk factors for pre-clinical atherosclerosis in adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2023;198:110618.","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"1974_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jamacardio.2018.2863","volume":"3","author":"CJ O\u2019Donnell","year":"2018","unstructured":"O\u2019Donnell CJ, Sabatine MS. Opportunities and Challenges in mendelian randomization studies to Guide Trial Design. JAMA Cardiol. 2018;3(10):967.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"1974_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","volume":"2","author":"E Sanderson","year":"2022","unstructured":"Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munaf\u00f2 MR, Palmer T, Schooling CM, Wallace C, Zhao Q, et al. Mendelian randomization. Nat Reviews Methods Primers. 2022;2(1):6.","journal-title":"Nat Reviews Methods Primers"},{"key":"1974_CR15","doi-asserted-by":"publisher","first-page":"840579","DOI":"10.3389\/fendo.2022.840579","volume":"13","author":"M Huang","year":"2022","unstructured":"Huang M, Laina-Nicaise LD, Zha L, Tang T, Cheng X. Causal Association of type 2 diabetes Mellitus and Glycemic Traits with Cardiovascular Diseases and lipid traits: a mendelian randomization study. Front Endocrinol (Lausanne). 2022;13:840579.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1974_CR16","doi-asserted-by":"crossref","unstructured":"Liu B, Mason AM, Sun L, Di Angelantonio E, Gill D, Burgess S. Genetically predicted type 2 diabetes Mellitus Liability, Glycated Hemoglobin and Cardiovascular Diseases: a wide-angled mendelian randomization study. Genes (Basel) 2021, 12(10).","DOI":"10.3390\/genes12101644"},{"key":"1974_CR17","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.1038\/ncomms8060","volume":"6","author":"OS Ahmad","year":"2015","unstructured":"Ahmad OS, Morris JA, Mujammami M, Forgetta V, Leong A, Li R, Turgeon M, Greenwood CM, Thanassoulis G, Meigs JB, et al. A mendelian randomization study of the effect of type-2 diabetes on coronary heart disease. Nat Commun. 2015;6:7060.","journal-title":"Nat Commun"},{"issue":"4","key":"1974_CR18","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2337\/db19-0831","volume":"69","author":"V Forgetta","year":"2020","unstructured":"Forgetta V, Manousaki D, Istomine R, Ross S, Tessier MC, Marchand L, Li M, Qu HQ, Bradfield JP, Grant SFA, et al. Rare genetic variants of large effect influence risk of type 1 diabetes. Diabetes. 2020;69(4):784\u201395.","journal-title":"Diabetes"},{"issue":"1","key":"1974_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/nar\/24.1.6","volume":"24","author":"P Rodriguez-Tom\u00e9","year":"1996","unstructured":"Rodriguez-Tom\u00e9 P, Stoehr PJ, Cameron GN, Flores TP. The european Bioinformatics Institute (EBI) databases. Nucleic Acids Res. 1996;24(1):6\u201312.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"1974_CR20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/eurheartj\/ehaa1040","volume":"42","author":"JA Hartiala","year":"2021","unstructured":"Hartiala JA, Han Y, Jia Q, Hilser JR, Huang P, Gukasyan J, Schwartzman WS, Cai Z, Biswas S, Tr\u00e9gou\u00ebt DA, et al. Genome-wide analysis identifies novel susceptibility loci for myocardial infarction. Eur Heart J. 2021;42(9):919\u201333.","journal-title":"Eur Heart J"},{"issue":"1","key":"1974_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","volume":"11","author":"S Shah","year":"2020","unstructured":"Shah S, Henry A, Roselli C, Lin H, Sveinbj\u00f6rnsson G, Fatemifar G, Hedman \u00c3K, Wilk JB, Morley MP, Chaffin MD, et al. Genome-wide association and mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat Commun. 2020;11(1):163.","journal-title":"Nat Commun"},{"issue":"3","key":"1974_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/CIRCRESAHA.117.312086","volume":"122","author":"P van der Harst","year":"2018","unstructured":"van der Harst P, Verweij N. Identification of 64 Novel genetic loci provides an expanded view on the Genetic Architecture of Coronary Artery Disease. Circul Res. 2018;122(3):433\u201343.","journal-title":"Circul Res"},{"issue":"9","key":"1974_CR23","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41588-018-0171-3","volume":"50","author":"JB Nielsen","year":"2018","unstructured":"Nielsen JB, Thorolfsdottir RB, Fritsche LG, Zhou W, Skov MW, Graham SE, Herron TJ, McCarthy S, Schmidt EM, Sveinbjornsson G, et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat Genet. 2018;50(9):1234\u20139.","journal-title":"Nat Genet"},{"issue":"4","key":"1974_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","volume":"50","author":"R Malik","year":"2018","unstructured":"Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, Rutten-Jacobs L, Giese AK, van der Laan SW, Gretarsdottir S, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50(4):524\u201337.","journal-title":"Nat Genet"},{"issue":"7944","key":"1974_CR25","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318.","journal-title":"Nature"},{"issue":"7769","key":"1974_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41586-019-1457-z","volume":"572","author":"AE Locke","year":"2019","unstructured":"Locke AE, Steinberg KM, Chiang CWK, Service SK, Havulinna AS, Stell L, Pirinen M, Abel HJ, Chiang CC, Fulton RS, et al. Exome sequencing of finnish isolates enhances rare-variant association power. Nature. 2019;572(7769):323\u20138.","journal-title":"Nature"},{"issue":"3","key":"1974_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2307\/2171753","volume":"65","author":"JHS Douglas Staiger","year":"1997","unstructured":"Douglas Staiger JHS. Instrumental variables regression with weak instruments. Econometrica. 1997;65(3):557\u201386.","journal-title":"Econometrica"},{"key":"1974_CR28","doi-asserted-by":"crossref","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife 2018, 7.","DOI":"10.7554\/eLife.34408"},{"key":"1974_CR29","doi-asserted-by":"crossref","unstructured":"Yavorska OO, Burgess S. MendelianRandomization: an R package for performing mendelian randomization analyses using summarized data. Int J Epidemiol 2017, 46(6):1734\u20139.","DOI":"10.1093\/ije\/dyx034"},{"issue":"7","key":"1974_CR30","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365.","journal-title":"Genet Epidemiol"},{"key":"1974_CR31","doi-asserted-by":"crossref","unstructured":"Pastore I, Bolla AM, Montefusco L, Lunati ME, Rossi A, Assi E, Zuccotti GV, Fiorina P. The impact of diabetes Mellitus on Cardiovascular Risk Onset in Children and Adolescents. Int J Mol Sci 2020, 21(14).","DOI":"10.3390\/ijms21144928"},{"issue":"6","key":"1974_CR32","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1161\/CIRCULATIONAHA.118.038137","volume":"139","author":"JR Petrie","year":"2019","unstructured":"Petrie JR, Sattar N. Excess Cardiovascular risk in type 1 diabetes Mellitus. Circulation. 2019;139(6):744\u20137.","journal-title":"Circulation"},{"issue":"13","key":"1974_CR33","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1161\/CIRCULATIONAHA.119.044539","volume":"141","author":"GR Sousa","year":"2020","unstructured":"Sousa GR, Kosiborod M, Bluemke DA, Lipes MA. Cardiac autoimmunity is Associated with subclinical myocardial dysfunction in patients with type 1 diabetes Mellitus. Circulation. 2020;141(13):1107\u20139.","journal-title":"Circulation"},{"issue":"8","key":"1974_CR34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.molmed.2020.03.011","volume":"26","author":"NO Stitziel","year":"2020","unstructured":"Stitziel NO, Kanter JE, Bornfeldt KE. Emerging targets for Cardiovascular Disease Prevention in Diabetes. Trends Mol Med. 2020;26(8):744\u201357.","journal-title":"Trends Mol Med"},{"key":"1974_CR35","doi-asserted-by":"crossref","unstructured":"Sanderson E. Multivariable mendelian randomization and mediation. Cold Spring Harbor Perspectives in Medicine 2021, 11(2).","DOI":"10.1101\/cshperspect.a038984"},{"issue":"14","key":"1974_CR36","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1161\/01.CIR.0000124725.46165.2C","volume":"109","author":"MJ Jarvisalo","year":"2004","unstructured":"Jarvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, Laine S, Lehtimaki T, Ronnemaa T, Viikari J, Raitakari OT. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation. 2004;109(14):1750\u20135.","journal-title":"Circulation"},{"issue":"3","key":"1974_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12098-022-04314-w","volume":"90","author":"PS Bharathy","year":"2023","unstructured":"Bharathy PS, Delhikumar CG, Rajappa M, Sahoo J, Anantharaj A. Early markers of atherosclerosis in children and adolescents with type 1 diabetes Mellitus. Indian J Pediatr. 2023;90(3):227\u201332.","journal-title":"Indian J Pediatr"},{"issue":"6","key":"1974_CR38","first-page":"668","volume":"20","author":"EZ Giannopoulou","year":"2019","unstructured":"Giannopoulou EZ, Doundoulakis I, Antza C, Christoforidis A, Haidich AB, Kotsis V, Stabouli S. Subclinical arterial damage in children and adolescents with type 1 diabetes: a systematic review and meta-analysis. Pediatr Diabetes. 2019;20(6):668\u201377.","journal-title":"Pediatr Diabetes"},{"key":"1974_CR39","doi-asserted-by":"crossref","unstructured":"Perez-Segura P, de Dios O, Herrero L, Vales-Villamarin C, Aragon-Gomez I, Gavela-Perez T, Garces C, Soriano-Guillen L. Children with type 1 diabetes have elevated high-sensitivity C-reactive protein compared with a control group. BMJ Open Diabetes Res Care 2020, 8(1).","DOI":"10.1136\/bmjdrc-2020-001424"},{"issue":"3","key":"1974_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/CRD.0000000000000021","volume":"22","author":"J Hartman","year":"2014","unstructured":"Hartman J, Frishman WH. Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol Rev. 2014;22(3):147\u201351.","journal-title":"Cardiol Rev"},{"issue":"10289","key":"1974_CR41","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/S0140-6736(21)00985-5","volume":"397","author":"M Christoffersen","year":"2021","unstructured":"Christoffersen M, Tybjaerg-Hansen A. Targeting IL-6 in patients at high cardiovascular risk. Lancet. 2021;397(10289):2025\u20137.","journal-title":"Lancet"},{"issue":"5","key":"1974_CR42","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1161\/HYPERTENSIONAHA.121.17981","volume":"78","author":"G Jia","year":"2021","unstructured":"Jia G, Sowers JR. Hypertension in diabetes: an update of Basic Mechanisms and Clinical Disease. Hypertension. 2021;78(5):1197\u2013205.","journal-title":"Hypertension"},{"key":"1974_CR43","doi-asserted-by":"publisher","first-page":"154890","DOI":"10.1016\/j.metabol.2021.154890","volume":"124","author":"CA Ricciardi","year":"2021","unstructured":"Ricciardi CA, Gnudi L. Kidney disease in diabetes: from mechanisms to clinical presentation and treatment strategies. Metabolism. 2021;124:154890.","journal-title":"Metabolism"},{"issue":"8","key":"1974_CR44","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.2337\/dc20-0170","volume":"43","author":"R Lithovius","year":"2020","unstructured":"Lithovius R, Harjutsalo V, Mutter S, Gordin D, Forsblom C, Groop PH, FinnDiane Study G. Resistant hypertension and risk of adverse events in individuals with type 1 diabetes: a nationwide prospective study. Diabetes Care. 2020;43(8):1885\u201392.","journal-title":"Diabetes Care"},{"issue":"10146","key":"1974_CR45","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","volume":"392","author":"A Rawshani","year":"2018","unstructured":"Rawshani A, Sattar N, Franzen S, Rawshani A, Hattersley AT, Svensson AM, Eliasson B, Gudbjornsdottir S. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet. 2018;392(10146):477\u201386.","journal-title":"Lancet"},{"issue":"1","key":"1974_CR46","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12933-022-01608-3","volume":"21","author":"AM Kerola","year":"2022","unstructured":"Kerola AM, Semb AG, Juonala M, Palomaki A, Rautava P, Kyto V. Long-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction. Cardiovasc Diabetol. 2022;21(1):177.","journal-title":"Cardiovasc Diabetol"},{"issue":"Suppl 2","key":"1974_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2337\/diabetes.54.suppl_2.S97","volume":"54","author":"M Cnop","year":"2005","unstructured":"Cnop M, Welsh N, Jonas JC, J\u00f6rns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes. 2005;54(Suppl 2):97\u2013107.","journal-title":"Diabetes"},{"issue":"3","key":"1974_CR48","doi-asserted-by":"publisher","first-page":"320","DOI":"10.7326\/0003-4819-99-3-320","volume":"99","author":"S Srikanta","year":"1983","unstructured":"Srikanta S, Ganda OP, Jackson RA, Gleason RE, Kaldany A, Garovoy MR, Milford EL, Carpenter CB, Soeldner JS, Eisenbarth GS. Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med. 1983;99(3):320\u20136.","journal-title":"Ann Intern Med"},{"issue":"12","key":"1974_CR49","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrendo.2013.131","volume":"9","author":"LA Velloso","year":"2013","unstructured":"Velloso LA, Eizirik DL, Cnop M. Type 2 diabetes mellitus\u2013an autoimmune disease? Nat Rev Endocrinol. 2013;9(12):750\u20135.","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"1974_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","volume":"16","author":"DL Eizirik","year":"2020","unstructured":"Eizirik DL, Pasquali L, Cnop M. Pancreatic beta-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol. 2020;16(7):349\u201362.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"1974_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ng.3245","volume":"47","author":"S Onengut-Gumuscu","year":"2015","unstructured":"Onengut-Gumuscu S, Chen WM, Burren O, Cooper NJ, Quinlan AR, Mychaleckyj JC, Farber E, Bonnie JK, Szpak M, Schofield E, et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat Genet. 2015;47(4):381\u20136.","journal-title":"Nat Genet"},{"issue":"11","key":"1974_CR52","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","volume":"50","author":"A Mahajan","year":"2018","unstructured":"Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW, Payne AJ, Steinthorsdottir V, Scott RA, Grarup N, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet. 2018;50(11):1505\u201313.","journal-title":"Nat Genet"},{"issue":"8","key":"1974_CR53","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S2213-8587(21)00139-X","volume":"9","author":"SE Gitelman","year":"2021","unstructured":"Gitelman SE, Bundy BN, Ferrannini E, Lim N, Blanchfield JL, DiMeglio LA, Felner EI, Gaglia JL, Gottlieb PA, Long SA, et al. Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol. 2021;9(8):502\u201314.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"1974_CR54","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00125-015-3669-6","volume":"58","author":"F Brozzi","year":"2015","unstructured":"Brozzi F, Nardelli TR, Lopes M, Millard I, Barthson J, Igoillo-Esteve M, Grieco FA, Villate O, Oliveira JM, Casimir M, et al. Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms. Diabetologia. 2015;58(10):2307\u201316.","journal-title":"Diabetologia"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01974-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01974-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01974-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T10:15:51Z","timestamp":1700475351000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01974-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,2]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1974"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01974-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.07.07.23292393","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,2]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"236"}}